Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction

JACC: Heart Failure - Tập 2 Số 2 - Trang 159-165 - 2014
Eldrin F. Lewis1, Yanhong Li2, Marc A. Pfeffer3, Scott D. Solomon3, Kevin P. Weinfurt2, Eric J. Velazquez2, Robert M. Califf2, Jean‐Lucien Rouleau4, Lars Køber5, Harvey D. White6, Kevin A. Schulman2, Shelby D. Reed2
1Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: [email protected].
2Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
3Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts
4Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada
5Rigshospitalet, Copenhagen, Denmark
6Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand

Tóm tắt

Từ khóa


Tài liệu tham khảo

Guidry, 1999, Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study, Circulation, 100, 2054, 10.1161/01.CIR.100.20.2054

Janardhanan, 2006, Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both, Am Heart J, 152, 183, 10.1016/j.ahj.2005.11.013

Sampson, 2007, Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial, Eur Heart J, 28, 685, 10.1093/eurheartj/ehl197

Solomon, 2005, Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both, N Engl J Med, 352, 2581, 10.1056/NEJMoa043938

Rumsfeld, 2003, History of depression, angina, and quality of life after acute coronary syndromes, Am Heart J, 145, 493, 10.1067/mhj.2003.177

Singh, 2011, Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization, Circ Cardiovasc Qual Outcomes, 4, 496, 10.1161/CIRCOUTCOMES.111.961375

Heidenreich, 2006, Health status identifies heart failure outpatients at risk for hospitalization or death, J Am Coll Cardiol, 47, 752, 10.1016/j.jacc.2005.11.021

Brink, 2005, Health-related quality of life in women and men one year after acute myocardial infarction, Qual Life Res, 14, 749, 10.1007/s11136-004-0785-z

Failde, 2006, Changes in health related quality of life 3 months after an acute coronary syndrome, BMC Public Health, 6, 18, 10.1186/1471-2458-6-18

Kim, 2005, Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of Unstable Angina (RITA-3), J Am Coll Cardiol, 45, 221, 10.1016/j.jacc.2004.10.034

Rumsfeld, 2001, Predictors of quality of life following acute coronary syndromes, Am J Cardiol, 88, 781, 10.1016/S0002-9149(01)01852-5

Beck, 2001, Predictors of quality of life 6 months and 1 year after acute myocardial infarction, Am Heart J, 142, 271, 10.1067/mhj.2001.116758

Aalto, 2006, Sociodemographic, disease status, and illness perceptions predictors of global self-ratings of health and quality of life among those with coronary heart disease—one year follow-up study, Qual Life Res, 15, 1307, 10.1007/s11136-006-0010-3

Pfeffer, 2000, Valsartan in acute myocardial infarction trial (VALIANT): rationale and design, Am Heart J, 140, 727, 10.1067/mhj.2000.108832

Pfeffer, 2003, Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both, N Engl J Med, 349, 1893, 10.1056/NEJMoa032292

Brazier, 1993, Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire, Qual Life Res, 2, 169, 10.1007/BF00435221

Nowels, 2005, Validation of the EQ-5D quality of life instrument in patients after myocardial infarction, Qual Life Res, 14, 95, 10.1007/s11136-004-0614-4

1990, EuroQol—a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9

Dolan, 1997, Modeling valuations for EuroQol health states, Med Care, 35, 1095, 10.1097/00005650-199711000-00002

Shaw, 2005, US valuation of the EQ-5D health states: development and testing of the D1 valuation model, Med Care, 43, 203, 10.1097/00005650-200503000-00003

Verbeke, 2000

Rutten-van Molken, 2006, Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?, Chest, 130, 1117, 10.1378/chest.130.4.1117

Eurich, 2006, Assessing responsiveness of generic and specific health related quality of life measures in heart failure, Health Qual Life Outcomes, 4, 89, 10.1186/1477-7525-4-89

Lewis, 2011, Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial, Clin J Am Soc Nephrol, 6, 845, 10.2215/CJN.06450710

Pickard, 2007, Health utilities using the EQ-5D in studies of cancer, Pharmacoeconomics, 25, 365, 10.2165/00019053-200725050-00002

Brown, 1999, Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population, Heart, 81, 352, 10.1136/hrt.81.4.352

Bengtsson, 2004, Lasting impact on health-related quality of life after a first myocardial infarction, Int J Cardiol, 97, 509, 10.1016/j.ijcard.2003.12.011

Simpson, 2005, Quality of life after acute myocardial infarction: a comparison of diabetic versus non-diabetic acute myocardial infarction patients in Quebec acute care hospitals, Health Qual Life Outcomes, 3, 80, 10.1186/1477-7525-3-80